The global Local Anesthesia Drugs Market size is anticipated to reach USD 6.45 billion by 2025, according to
a new report by Grand View Research, Inc., registering a 3.7% CAGR during the
forecast period. Rising number of surgical procedures across the globe,
including cosmetic surgeries, dental procedures, and plastic surgeries, is
driving the growth of local anesthetics.
There has been a considerable increase in number of
surgical procedures requiring post-operative pain relief and this trend is
expected to continue throughout the forecast period. Roughly, 65.0% of total
surgical procedures require post-operative pain management. This is likely to
boost the demand for local anesthesia drugs.
Introduction of new and effective drugs such as
levobupivacaine, articaine, and ropivacaine is also driving the growth of the
local anesthesia drugs market across the globe. Rising healthcare expenditure
in developing countries is expected to result in an increase in number of
surgeries performed in countries such as India, China, and Brazil. This is
likely to contribute to market growth in the region.
Browse
Details of Report @
https://www.grandviewresearch.com/industry-analysis/local-anesthesia-drugs-market
https://www.grandviewresearch.com/industry-analysis/local-anesthesia-drugs-market
Further key findings from the study suggest:
- Lidocaine dominated the market by product as of 2016 owing to its
extensive use as topical and injectable anesthetic
- By application, the market is bifurcated into injectable and surface
anesthetic. The injectable segment is expected to dominate the local anesthesia
drugs market during the forecast period owing to extensive usage in
different surgical procedures. Advancements in drug delivery systems is
expected to drive the market for surface anesthetics over the forecast
period
- North America held the largest share in the market for local
anesthesia drugs owing to significant number of surgical procedures
performed in the region
- Some of the key players are Aspen Pharmacare; Fresenius Kabi;
Novartis, Inc.; Sagent Pharmaceutical; Pacira Pharmaceutical; Mylan; and
Teva Pharmaceuticals.
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment